---
title: "Mobile clinical research specialist Hawthorne Effect appoints new CEO"
date: "2024-03-01T14:17:24.000Z"
publishedDate: "1 mars 2024"
summary: "Hawthorne Effect, a specialist in technology-enabled mobile clinical research, announced the appointment of Josh Rose as new CEO. The organisation describes Rose as a clinical trial industry veteran with over 14 years of executive leadership experience with companies such as IQVIA, CVS Health and others."
importance: ""
sourceUrl: "https://cardiovascularnews.com/mobile-clinical-research-specialist-hawthorne-effect-appoints-new-ceo/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-03-01-mobile-clinical-research-specialist-hawthorne-effect-appoints-new-ceo"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Josh_Rose_Headshot-2023-copy.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/mobile-clinical-research-specialist-hawthorne-effect-appoints-new-ceo/"
---

![Mobile clinical research specialist Hawthorne Effect appoints new CEO](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Josh_Rose_Headshot-2023-copy.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/mobile-clinical-research-specialist-hawthorne-effect-appoints-new-ceo/*

## L’essentiel

Hawthorne Effect, a specialist in technology-enabled mobile clinical research, announced the appointment of Josh Rose as new CEO. The organisation describes Rose as a clinical trial industry veteran with over 14 years of executive leadership experience with companies such as IQVIA, CVS Health and others.

## Lien source

https://cardiovascularnews.com/mobile-clinical-research-specialist-hawthorne-effect-appoints-new-ceo/
